Ulcerative colitis: open trials in Austria

14 open trials have a site in Austria. Registry data; only the trial team decides who can take part.

NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
Medizinische Universität Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Medizinische Universität Wien, Vienna
Registry updated 2026-11-04
NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Trial Treatment · Phase 2 · Eli Lilly and Company
Medizinische Universität Wien, Vienna
Registry updated 2026-11-04
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Medical University of Graz, Graz · Landeskrankenanstalten-Betriebsgesellschaft Kabeg, Klagenfurt Am Woerthersee · Johannes Kepler University Linz, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Noe LGA Gesundheit Region Mitte GmbH, St. Poelten · Krankenhaus Der Barmherzigen Brueder Wien, Vienna · Klinikum Wels-Grieskirchen GmbH, Wels
Registry updated 2026-11-03
NCT07606339
A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis
Research · Janssen-Cilag Pharma GmbH
Medical University Vienna, Vienna
Registry updated 2026-11-03
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Medizinische Universitaet Innsbruck, Innsbruck · Johannes Kepler University Linz, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg
Registry updated 2026-11-03
NCT05287126
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Trial Treatment · Phase 2 · Pfizer
Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH, Salzburg
Registry updated 2026-10-27
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Medizinische Universitaet Innsbruck, Innsbruck · Johannes Kepler University Linz, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Krankenhaus Der Barmherzigen Brueder Wien, Vienna
Registry updated 2026-10-27
NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Vienna
Registry updated 2026-10-23
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Krems · Salzburg
Registry updated 2026-10-16
2025-522338-30-00
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
Trial Treatment · Phase 2 · Eli Lilly & Co.
Medical University of Vienna, Vienna
Registry updated 2026-10-07
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Trial Treatment · Phase 3 · Eli Lilly and Company
Medizinische Universität Wien, Vienna
Registry updated 2026-10-07
2024-520201-39-00
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Odyssey Therapeutics Inc.
Medical University of Graz, Graz
Registry updated 2026-07-31
NCT06850727
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Odyssey Therapeutics, Inc.
Medical University of Graz, Graz
Registry updated 2026-02-11
NCT06954311
Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
Research · Medical University Innsbruck
Landeskrankenhaus Feldkirch, Feldkirch · Universitätsklinikum Graz / Medizinische Universität Graz, Graz · Medical University of Innsbruck, Innsbruck · Klinikum Klagenfurt, Klagenfurt · Kepler Universitätsklinikum Linz, Linz · Paracelsus Medizinische Privatuniversität, Salzburg · Klinik Donaustadt, Vienna · Universitätsklinik für Kinder- und Jugendheilkunde, Vienna · St. Anna Kinderspital, Vienna · Landeskrankenhaus Villach, Villach
Registry updated 2025-05-01

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error